News + Filings Transactions
|
Silverman Joshua
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 08/01/2023 | AYRO, Inc. | DCAR | Sale | Common Stock | 12.7k | $0.82 | $10.4k | | 08/01/2023 |
| 06/07/2023 | MyMD Pharmaceuticals, Inc. | AKER | Grant | Employee Stock Option (Right to Buy) | 200k | $1.66 | $332k | | 06/07/2023 |
| 05/03/2023 | AYRO, Inc. | DCAR | Sale | Common Stock | 11.9k | $0.49 | $5.8k | | 05/03/2023 |
| 04/26/2023 | Petros Pharmaceuticals, Inc. | | Exercise | Restricted Stock Units | 6.7k | $0.00 | $0 | | 04/26/2023 |
| 03/29/2023 | Synaptogenix, Inc. | SNPX | Grant | Stock Option (Right to Buy) | 20k | $0.87 | $17.4k | | 03/29/2023 |
| 02/01/2023 | AYRO, Inc. | DCAR | Grant | Common Stock | 197.3k | $0.00 | $0 | | 01/30/2023 |
| 01/30/2023 | AYRO, Inc. | DCAR | Sale | Common Stock | 7.2k | $0.71 | $5.1k | | 01/30/2023 |
| 01/20/2023 | Petros Pharmaceuticals, Inc. | | Exercise | Restricted Stock Units | 2.5k | $0.00 | $0 | | 01/20/2023 |
| 12/16/2022 | Synaptogenix, Inc. | SNPX | Sale | Common Stock, par value $0.0001 per share | 19k | $1.17 | $22.3k | | 12/16/2022 |
| 11/15/2022 | Synaptogenix, Inc. | SNPX | Grant | Stock Option (Right to Buy) | 144k | $6.07 | $874.1k | | 11/15/2022 |
| 11/15/2022 | Synaptogenix, Inc. | SNPX | Grant | Stock Option (Right to Buy) | 75k | $6.07 | $455.2k | | 11/15/2022 |
| 04/07/2022 | Petros Pharmaceuticals, Inc. | | Grant | Restricted Stock Units | 67.2k | $0.00 | $0 | | 04/07/2022 |
| 04/05/2022 | Synaptogenix, Inc. | SNPX | Other (acquisition) | | 0 | $0.00 | $0 | | 04/05/2022 |
| 04/05/2022 | Synaptogenix, Inc. | SNPX | Grant | Stock Option (Right to Buy) | 1.5k | $7.41 | $11.1k | | 04/05/2022 |
| 12/22/2021 | Petros Pharmaceuticals, Inc. | | Grant | Restricted Stock Units | 25.2k | $0.00 | $0 | | 12/22/2021 |
| 11/26/2021 | MyMD Pharmaceuticals, Inc. | AKER | Purchase | Common Stock | 5k | $7.55 | $37.8k | | 11/24/2021 |
| 11/24/2021 | MyMD Pharmaceuticals, Inc. | AKER | Purchase | Common Stock | 6.7k | $6.30 | $42.4k | | 11/24/2021 |
| 11/24/2021 | MyMD Pharmaceuticals, Inc. | AKER | Purchase | Common Stock | 3.3k | $7.09 | $23.2k | | 11/24/2021 |
| 10/14/2021 | MyMD Pharmaceuticals, Inc. | AKER | Grant | Restricted Stock Units | 600k | $0.00 | $0 | | 10/14/2021 |
| 07/13/2021 | Synaptogenix, Inc. | SNPX | Grant | Common Stock, par value $0.0001 per share | 90k | $0.00 | $0 | | 07/13/2021 |
| 07/13/2021 | Synaptogenix, Inc. | SNPX | Grant | Common Stock, par value $0.0001 per share | 42.2k | $0.00 | $0 | | 07/13/2021 |
| 06/14/2021 | Synaptogenix, Inc. | SNPX | Purchase | Common Stock, par value $0.0001 per share | 10k | $8.30 | $83k | | 06/14/2021 |
| 06/04/2021 | AYRO, Inc. | DCAR | Sale | Common Stock | 39k | $5.17 | $201.7k | | 06/04/2021 |
| 04/16/2021 | MyMD Pharmaceuticals, Inc. | AKER | Payment of Exercise | Common Stock | 38.3k | $4.94 | $189.3k | | 04/16/2021 |
| 04/16/2021 | MyMD Pharmaceuticals, Inc. | AKER | Exercise | Restricted Stock Units | 109.5k | $0.00 | $0 | | 04/16/2021 |
| 04/08/2021 | Petros Pharmaceuticals, Inc. | | Grant | Stock Option (right to buy) | 50k | $3.18 | $159k | | 04/08/2021 |
| 02/24/2021 | AYRO, Inc. | DCAR | Grant | Common Stock | 42k | $0.00 | $0 | | 02/24/2021 |
| 12/01/2020 | Neurotrope, Inc. | NTRP | Disposition | Stock Option (right to buy) | 100k | $0.97 | $97.2k | | 12/01/2020 |
| 12/01/2020 | Neurotrope, Inc. | NTRP | Disposition | Common Stock | 100k | $0.00 | $0 | | 12/01/2020 |
| 12/01/2020 | Neurotrope, Inc. | NTRP | Disposition | Stock Option (right to buy) | 9.4k | $19.20 | $180k | | 12/01/2020 |
| 12/01/2020 | Neurotrope, Inc. | NTRP | Disposition | Stock Option (right to buy) | 124.3k | $10.56 | $1.3M | | 12/01/2020 |
| 12/01/2020 | Neurotrope, Inc. | NTRP | Disposition | Stock Option (right to buy) | 10k | $19.10 | $191k | | 12/01/2020 |
| 12/01/2020 | Neurotrope, Inc. | NTRP | Disposition | Stock Option (right to buy) | 167k | $19.62 | $3.3M | | 12/01/2020 |
| 12/01/2020 | Neurotrope, Inc. | NTRP | Disposition | Stock Option (right to buy) | 10k | $8.91 | $89.1k | | 12/01/2020 |
| 12/01/2020 | Neurotrope, Inc. | NTRP | Disposition | Stock Option (right to buy) | 150k | $3.93 | $589.5k | | 12/01/2020 |
|
|